skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

Neuropsychiatric Disease and Treatment

(2,361,158) Views

Editor in Chief Dr Roger M Pinder

1176-6328

Case report
Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis
Andreas Rogalewski, Jörg Kraus, Martin Hasselblatt, Christoffer Kraemer, Wolf-Rüdiger Schäbitz
Neuropsychiatric Disease and Treatment 2007, 3:987-991
21 January 2007

Case report
Towards a cognitive stimulation program using an errorless learning paradigm in amnestic mild cognitive impairment
Léonie Jean, Martine Simard, Robert van Reekum, Marie-Ève Bergeron
Neuropsychiatric Disease and Treatment 2007, 3:975-985
21 January 2007

Case report
Pharmacogenetics of antipsychotic adverse effects: Case studies and a literature review for clinicians
Adriana Foster, Zixuan Wang, Manzoor Usman, Edna Stirewalt, Peter Buckley
Neuropsychiatric Disease and Treatment 2007, 3:965-973
21 January 2007

Rapid Communication
Early rising children are more active than late risers
Jun Kohyama
Neuropsychiatric Disease and Treatment 2007, 3:959-963
21 January 2007

Original Research
Cognitive decline tracks motor progression and not disease duration in Parkinson patients
BD Riggeal, GP Crucian, P Seignourel, CE Jacobson IV, MS Okun, et al
Neuropsychiatric Disease and Treatment 2007, 3:955-958
21 January 2007

Original Research
Effects of psycho-educational training and stimulant medication on visual perceptual skills in children with attention deficit hyperactivity disorder
Antigone S Papavasiliou, Irene Nikaina, Ioanna Rizou, Stratos Alexandrou
Neuropsychiatric Disease and Treatment 2007, 3:949-954
21 January 2007

Original Research
Rivastigmine in Chinese patients with subcortical vascular dementia
Vincent Mok, Adrian Wong, Simon Ho, Thomas Leung, Wynnie WM Lam, et al
Neuropsychiatric Disease and Treatment 2007, 3:943-948
21 January 2007

Original Research
Urban–rural differences in pediatric traumatic head injuries: A prospective nationwide study
Jonas G Halldorsson, Kjell M Flekkoy, Kristinn R Gudmundsson, Gudmundur B Arnkelsson, Eirikur Orn Arnarson
Neuropsychiatric Disease and Treatment 2007, 3:935-941
21 January 2007

Original Research
Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions
Winnie W Leung, Margaret M McClure, Larry J Siever, Deanna M Barch, Philip D Harvey
Neuropsychiatric Disease and Treatment 2007, 3:925-934
21 January 2007


Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
Gaby Abraham, Roumen Milev, Lauren Lazowski, Ruzica Jokic, Regina du Toit, et al
Neuropsychiatric Disease and Treatment 2007, 3:919-924
21 January 2007

Original Research
Rule knowledge aids performance on spatial and object alternation tasks by alcoholic patients with and without Korsakoff’s amnesia
Fiona J Bardenhagen, Marlene Oscar-Berman, Stephen C Bowden
Neuropsychiatric Disease and Treatment 2007, 3:907-918
21 January 2007

Original Research
The patients’ perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD
Irene Hegeman Richard, Kori A LaDonna, Rosanne Hartman, Carol Podgorski, Roger Kurlan, et al
Neuropsychiatric Disease and Treatment 2007, 3:903-906
21 January 2007

Original Research
Depressive mixed state: Evidence for a new form of depressive state in type I and II bipolar patients
Katia M’Bailara, Donatienne Van den Bulke, Nicolas Demazeau, Jacques Demotes-Mainard, Chantal Henry
Neuropsychiatric Disease and Treatment 2007, 3:899-902
21 January 2007

Review
What is the impact of physician communication and patient understanding in the management of headache?
Meenal Patwardhan, Remy R Coeytaux, Rajeshwari Deshmukh, Gregory Samsa
Neuropsychiatric Disease and Treatment 2007, 3:893-897
21 January 2007

Review
Clinical use of pregabalin in the management of central neuropathic pain
Nanna B Finnerup, Troels S Jensen
Neuropsychiatric Disease and Treatment 2007, 3:885-891
20 January 2007

Review
Paliperidone ER: a review of the clinical trial data
Philip G Janicak, Elizabeth A Winans
Neuropsychiatric Disease and Treatment 2007, 3:869-883
20 January 2007

Review
A review of quetiapine in combination with antidepressant therapy in patients with depression
Ella J Daly, Madhukar H Trivedi
Neuropsychiatric Disease and Treatment 2007, 3:855-867
20 January 2007

Review
Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
Prashant Gajwani, David J Muzina, David E Kemp, Keming Gao, Joseph R Calabrese
Neuropsychiatric Disease and Treatment 2007, 3:847-853
20 January 2007

Expert Opinion
Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
Steven C Stoner, Megan M Dahmen
Neuropsychiatric Disease and Treatment 2007, 3:839-846
20 January 2007

Expert Opinion
The therapeutic potential of escitalopram in the treatment of panic disorder
Mark H Townsend, Erich J Conrad
Neuropsychiatric Disease and Treatment 2007, 3:835-838
20 January 2007

Expert Opinion
Ziprasidone in the treatment of mania in bipolar disorder
Stephen E Nicolson, Charles B Nemeroff
Neuropsychiatric Disease and Treatment 2007, 3:823-834
20 January 2007

Expert Opinion
Topiramate in the treatment of partial and generalized epilepsy
Edward Faught
Neuropsychiatric Disease and Treatment 2007, 3:811-821
20 January 2007

Review
Almotriptan in the treatment of migraine
Giorgio Sandrini, Armando Perrotta, Natalia L Arce Leal, Simona Buscone, Giuseppe Nappi
Neuropsychiatric Disease and Treatment 2007, 3:799-809
20 January 2007

Expert Opinion
Neurologic uses of botulinum neurotoxin type A
John P Ney, Kevin R Joseph
Neuropsychiatric Disease and Treatment 2007, 3:785-798
20 January 2007

Review
Rivastigmine for the treatment of dementia associated with Parkinson’s disease
Jennifer L Reingold, John C Morgan, Kapil D Sethi
Neuropsychiatric Disease and Treatment 2007, 3:775-783
11 May 2007

Review
Indiplon in the treatment of sleep disorders
Alan Lankford
Neuropsychiatric Disease and Treatment 2007, 3:765-773
20 January 2007

Expert Opinion
Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache
Stefan Evers
Neuropsychiatric Disease and Treatment 2007, 3:761-764
11 May 2007

Review
Adult neural stem cells: The promise of the future
Philippe Taupin
Neuropsychiatric Disease and Treatment 2007, 3:753-760
20 January 2007

Review
A review on primary progressive aphasia
Gabriel C Léger, Nancy Johnson
Neuropsychiatric Disease and Treatment 2007, 3:745-752
20 January 2007

Review
Sleep disturbances and suicide risk: A review of the literature
Rebecca A Bernert, Thomas E Joiner
Neuropsychiatric Disease and Treatment 2007, 3:735-743
20 January 2007

Review
Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy
Stéphane Auvin
Neuropsychiatric Disease and Treatment 2007, 3:729-734
20 January 2007

Review
Management of epilepsy in the elderly
Juan José Poza
Neuropsychiatric Disease and Treatment 2007, 3:723-728
20 January 2007

Review
Role of endocannabinoids in regulating drug dependence
Daniela Parolaro, Daniela Vigano’, Natalia Realini, Tiziana Rubino
Neuropsychiatric Disease and Treatment 2007, 3:711-721
18 January 2007

Review
Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
Christopher L Edwards, Renee Dunn Raynor, Miriam Feliu, Camela McDougald, Stephanie Johnson, et al
Neuropsychiatric Disease and Treatment 2007, 3:705-709
18 January 2007


Editorial: Botulinum toxin – From WMD to therapeutic agent and cosmetic aid ||Free Paper||
Roger M Pinder
Neuropsychiatric Disease and Treatment 2007, 3:703-704
18 January 2007